Neuropsychopharmacology
- Targeting inhibitory control in youth irritability: challenges and opportunities1 year ago
- Targeting depression circuitry with H1 coil Transcranial Magnetic Stimulation: a retrospective circuit mapping study1 year ago
- Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors1 year ago
- Anti-seizure effects of WS-3, a TRPM8 agonist, on focal onset seizure mouse model via reduction of extracellular glutamate levels1 year ago
- Using causal network mapping to clarify pre-clinical brain stimulation results1 year ago
- Neurobiology of resilience to early life stress1 year ago
- The mesolimbic reward pathway is necessary for disruptions in cocaine-seeking behavior following mediated devaluation1 year ago
Journal of Psychopharmacology
- The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?2 years ago
- Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks2 years ago
- Influence of GABAA and GABAB receptor activation on auditory sensory gating and its association with anxiety in healthy volunteers2 years ago
- Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database2 years ago
- Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants2 years ago
- Psychedelics and the ‘inner healer’: Myth or mechanism?2 years ago
- Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review2 years ago
European Neuropsychopharmacology
- Prescribing therapeutic apps within National Health Services: The critical role of evaluation and monitoring2 years ago
- Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression2 years ago
- Antidepressant use in bipolar disorder: Shifting focus from ‘Whether’ to ‘Whom’2 years ago
- Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials2 years ago
- Eli Robins: The grandfather of DSM-III2 years ago
- How do lipids fit into the picture of severe mental health disorders? A missing pathophysiologic link or just a consequence of behavior and treatment2 years ago
- Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis2 years ago